References
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54(3).
- Den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, et al. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet. 1995; 345:882-5.
- Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62-69.
- Genyan Yang, Christine De Staercke, and W. Craig Hooper. The effects of obesity on venous hromboembolism: A review. Open J Prev Med. 2012;2(4):499-509.
- Bernard Bagattini S, Bounameaux H, Perneger T, Perrier A. Suspicion of pulmonary embolism in outpatients: nonspecific chest pain is the most frequent alternative diagnosis. J Intern Med. 2004 Aug; 256(2):153-60.
- Herrmann M, Whiting MJ, Veillard A, Ehnholm C, Sullivan DR, Keech AC. Plasma homocysteine and the risk of venous thromboembolism: insights from the FIELD study. Clin Chem Lab Med. 2012;50:2213-9.
- Brustolin S, Giugliani R, Félix TM. Genetics of homocysteine metabolism and associated disorders. Braz J Med Biol Res. 2010 Jan;43(1):1-7.
- Radovanovic N, Antonijevic N, Beletic A et al. Hyperhomocystinemia in patients with pulmonary embolism. Arch Biol Sci. 2010; 62(4):907-914.
- Ekim M, Ekim H, Keser Yilmaz Y, et al. Study on relationships among deep vein thrombosis, homocysteine and related B group vitamins. Pak J Med Sci. 2015;31(2):398-402.
- Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6
- Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocysteinemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14:1080-3.
- Sule AA, Chin TJ, Khien H. Recurrent unprovoked venous thromboembolism in a young female patient with high levels of homocysteine. Int J Angiol. 2012;21:95-8.
- Vučković BA, Cannegieter SC, van Hylckama Vlieg A, Rosendaal FR, Lijfering WM. Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow-up study. J Thromb Haemost. 2017 Jul;15(7):1430-1435.
- Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol. 2013;20(5):437-444
- Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118:978-980.
- Han MS, Jung DY, Morel C, et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science. 2013;339:218-222.
- Wang TF, Squizzato A, Dentali F, Ageno W. The role of thrombolytic therapy in pulmonary embolism. Blood. 2015;125(14):2191-2199.
- Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008;133(6 Suppl):454S-545S.
- Canonico M, Oger E, Conard J, Meyer G, Levesque H, Trillot N, et al. Obesity and risk of venous thromboem-bolism among postmenopausal women: Differential impact of hormone therapy by route of estrogen administration. The ESTHER study. Journal of Thrombosis and Haemostasis. 2006;4:1259-1265.
- Van Schouwenburg IM, Mahmoodi BK, Veeger NJGM, Bakker SJL, Meijer K, et al. Insulin resistance and risk of venous thromboembolism: Results of a population-based cohort study. Journal of Thrombosis and Haemostasis. 2012;10:1012-1018.
- Wongn C, Moderate risk factor is thromvophilia and obesity is low risk factor.J Investig Med High Impact Case Rep. 2018 Jan-Dec; 6: 2324709617754117.
- Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348:1435-41.
- The relationship between unprovoked venous thromboembolism, age, and acute myocardial infarction. J Thromb Haemost 2008;6:1507-13.